Jaguar Health Inc JAGX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:48 PM EDT
0.16quote price arrow up+0.00 (+1.28%)
Volume
23,407
Close
0.156quote price arrow down-0.0047 (-2.9247%)
Volume
2,703,679
52 week range
0.15 - 2.66
Loading...
  • Open0.1614
  • Day High0.17
  • Day Low0.155
  • Prev Close0.1607
  • 52 Week High2.66
  • 52 Week High Date10/26/21
  • 52 Week Low0.15
  • 52 Week Low Date09/27/22

Key Stats

  • Market Cap18.70M
  • Shares Out119.86M
  • 10 Day Average Volume3.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.74
  • YTD % Change-85

KEY STATS

  • Open0.1614
  • Day High0.17
  • Day Low0.155
  • Prev Close0.1607
  • 52 Week High2.66
  • 52 Week High Date10/26/21
  • 52 Week Low0.15
  • 52 Week Low Date09/27/22
  • Market Cap18.70M
  • Shares Out119.86M
  • 10 Day Average Volume3.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.74
  • YTD % Change-85

RATIOS/PROFITABILITY

  • EPS (TTM)-0.93
  • P/E (TTM)-0.17
  • Fwd P/E (NTM)-0.40
  • EBITDA (TTM)-36.762M
  • ROE (TTM)-312.21%
  • Revenue (TTM)8.26M
  • Gross Margin (TTM)75.81%
  • Net Margin (TTM)-654.85%
  • Debt To Equity (MRQ)1,152.87%

EVENTS

  • Earnings Date11/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Jaguar Health Inc

 

Content From Our Affiliates

Profile

MORE
Jaguar Health, Inc. is a commercial stage pharmaceutical company. The Company is focused on developing plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with gastrointestinal (GI) distress, including chronic and debilitating diarrhea. The Company operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for...
James Bochnowski
Independent Chairman of the Board
Lisa Conte
President, Chief Executive Officer, Director
Carol Lizak
Chief Financial Officer
Address
200 PINE STREET SUITE 400
San Francisco, CA
94104
United States

Top Peers

SYMBOLLASTCHG%CHG
CALA
Calithera Biosciences Inc
2.94-0.02-0.68%
APVO
Aptevo Therapeutics Inc
3.04+0.09+3.05%
SGTX
Sigilon Therapeutics Inc
0.505+0.025+5.21%
PRPO
Precipio Inc
0.804-0.0532-6.2063%
HTGM
HTG Molecular Diagnostics Inc
0.6132+0.0132+2.20%